Konstantin Poukalov is Director & 10% Owner at Landos Biopharma, Inc. (LABP). They have made 3 open-market trades across 2 companies since 2016, most recently 2024-02-15.
CIK 0001678736
3 open-market purchases totalling $25.5M since 2016, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.